Browsing by Author Spruyt, O

Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)
2-May-2018A randomized open-label study of guideline-driven antiemetic therapy versus single agent antiemetic therapy in patients with advanced cancer and nausea not related to anticancer treatmentHardy, J; Skerman, H; Glare, P; Philip, J; Hudson, P; Mitchell, G; Martin, P; Spruyt, O; Currow, D; Yates, P
1-Sep-2016Pharmacovigilance in hospice/palliative care: Net effect of pregabalin for neuropathic painSanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC
1-Jan-2015Pharmacovigilance in hospice/palliative care: Net effect of gabapentin for neuropathic painSanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC
1-Jan-2014Implementing practice change in chronic cancer pain management: Clinician response to a phase III study of ketamineHardy, JR; Spruyt, O; Quinn, SJ; Devilee, LR; Currow, DC
1-Nov-2013Placebo and nocebo effects in randomized controlled trials: The implications for research and practiceSanderson, C; Hardy, J; Spruyt, O; Currow, DC
10-Oct-2012Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer painHardy, J; Quinn, S; Fazekas, B; Plummer, J; Eckermann, S; Agar, M; Spruyt, O; Rowett, D; Currow, DC
1-Jan-2012Defining refractory pain in cancer for clinicians and researchersCurrow, DC; Spruyt, O; Hardy, J